Abstract

The human airway epithelium lining the bronchial tree contains basal cells that proliferate, differentiate, and communicate with other components of their microenvironment. One method that cells use for intercellular communication involves the secretion of exosomes and other extracellular vesicles (EVs). We isolated exosome-enriched EVs that were produced from an immortalized human airway basal cell line (BCi-NS1.1) and found that their secretion is increased by exposure to cigarette smoke extract, suggesting that this stress stimulates release of EVs which could affect signaling to other cells. We have previously shown that primary human airway basal cells secrete vascular endothelial growth factor A (VEGFA) which can activate MAPK signaling cascades in endothelial cells via VEGF receptor–2 (VEGFR2). Here, we show that exposure of endothelial cells to exosome-enriched airway basal cell EVs promotes the survival of these cells and that this effect also involves VEGFR2 activation and is, at least in part, mediated by VEGFA present in the EVs. These observations demonstrate that EVs are involved in the intercellular signaling between airway basal cells and the endothelium which we previously reported. The downstream signaling pathways involved may be distinct and specific to the EVs, however, as increased phosphorylation of Akt, STAT3, p44/42 MAPK, and p38 MAPK was not seen following exposure of endothelial cells to airway basal cell EVs.

Details

Title
Extracellular vesicles from human airway basal cells respond to cigarette smoke extract and affect vascular endothelial cells
Author
Saxena Ashish 1 ; Walters, Matthew S 2 ; Jae-Hung, Shieh 3 ; Ling-Bo, Shen 4 ; Gomi Kazunori 5 ; Downey, Robert J 6 ; Crystal, Ronald G 7 ; Moore, Malcolm A, S 8 

 Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Department of Cell Biology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Weill Cornell Medicine, Department of Medicine, Division of Hematology and Medical Oncology, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Weill Cornell Medicine, Department of Genetic Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); University of Oklahoma Health Sciences Center, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618) 
 Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Department of Cell Biology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Weill Cornell Medicine, Department of Pathology and Laboratory Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Department of Cell Biology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Memorial Sloan Kettering Cancer Center, Cell Therapy and Cell Engineering Facility, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Weill Cornell Medicine, Department of Genetic Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Memorial Sloan Kettering Cancer Center, Thoracic Service, Department of Surgery, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Weill Cornell Medicine, Department of Genetic Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Department of Cell Biology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2502043196
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.